6 research outputs found
Factors Affecting The Saudi Gen-Z To Adopt The Metaverse Workplace : Application Of Utaut2
No full textThe metaverse concept gained traction, notably in 2021, when Facebook changed its name to Meta
and Nvidia's CEO stated that the company's next step would be establishing a metaverse. However,
the historical context is rarely presented; in 1992, American author Neal Stephenson's science
fiction novel Snow Crash introduced the metaverse concept for the first time. In Snow Crash, the
protagonists morph into avatars and function in the metaverse, a three-dimensional (3D) virtual
Reality. This notion evolved and took on several shapes. Augmented Reality, Virtual Reality,
lifelogging, and Mirror World users have significantly impacted an individual level and society in
various fields such as education, health, and the workplace. This research paper is determined to
measure the potential of gen z in the Kingdom of Saudi Arabia to adopt the concept of the
"metaverse workplace" by developing a thorough grasp of the factors that influence the Saudi Z -
generation's attraction to the digital realm of the metaverse as a new career prospect for future
growth. Using Google Forms, a quantitative questionnaire with 18 items was employed as the data
collection strategy for the methodology. Range from short answer questions to ranking questions
to multiple choice questions. to the intended audience. Which are "Gen Z," who are now enrolled
in universities. The number of respondents are 250 and the results show that performance and
facilitating conditioning are the most significant elements to the process of adopting the metaverse
work place . Due to the paucity of research on this topic in Saudi Arabia, this study has added to
the body of knowledge in this area
Patients’ willingness to pay for health care quality improvement under universal healthcare coverage in Egypt
No full textAbstract Background In economics, the word “willingness to pay” refers to the highest amount that an individual would be willing to pay, give up, or exchange to obtain goods or services or to avoid something undesirable. It can be applied in healthcare as a way to evaluate the worth of improving the quality of health services. This study aims to assess patients’ willingness to pay (WTP) for healthcare quality improvement among hospitalized patients in two hospitals in Egypt. Methods Four-hundred and twenty-six patients were asked to provide a rating for different quality attributes. Patients were presented with a hypothetical scenario and asked about their WTP for a monthly insurance premium to benefit from improving each quality attribute. WTP was elicited using the payment card (PC) response format. Results Fifty-two percent of studied patients were not willing to pay to improve healthcare quality attributes. Fifty percent of those who were willing to pay were certain to pay. The most commonly stated reasons for unwillingness to pay were “being governmental responsibility” and “household cannot afford” (43% and 36.8%, respectively). Patients were willing to pay the highest amount of money to improve the quality attributes “competence,” followed by “outcome” and “doctor-patient relationship” (491.03, 465, and 423 LE, respectively). For all quality attributes, except for waiting time and availability of supplies and equipment, the amount of money the patients were willing to pay increased significantly as the perceived quality of that attribute reduced. Advancing age had a significant negative association with WTP (p = 0.002). Also, advancement in education was associated with significantly higher WTP (p < 0.001). Those with health expenditures ranging from 2000 to < 6000 LE per month were 3.38 times more willing to pay than those with health expenditures ranging from 200 to 1000 LE (p < 0.001). Conclusion WTP for quality improvement among study participants was low, being the lowest among the elderly and lower-educated individuals. Community financing should not be a method for funding quality improvements except for a few quality attributes such as doctor-patient communication and increased doctor competence. This should be coupled with clear exemption criteria for those unable to pay
Oncological Safety of Lipofilling in Patients with Breast Cancer: A Metaanalysis
No full textAbstract
Background
Lipofilling is an increasingly popular technique for breast reconstruction following both mastectomy and breast-conserving surgery (BCS). Autologous fat transfer (Lipofilling), is a technique which has been used for many years in the setting of aesthetic breast surgery. Although gaining popularity in this setting, there are still questions regarding its oncological safety when used in patients being treated for breast cancer.
Objective
To systematically evaluate the current literature regarding the oncological safety of lipofilling in patients who underwent surgical treatment for breast cancer by performing a metaanalysis to investigate the recurrence rates and the incidence of complications after lipofilling. Data Sources: Medline databases (PubMed, Medscape, ScienceDirect. EMF-Portal) and all materi als available in the Internet till 2019.
Data Extraction
All the studies which did not fulfill the inclusion criteria were excluded. Study quality assessment included whether ethical approval was gained, eligibility criteria specified, appropriate controls, and adequate information and defined assessment measures.
Conclusion
Through this analysis, no evidence that lipofilling significantly increases the risk of locoregional recurrence when used as part of a breast reconstruction procedure after either mastectomy or BCS for breast cancer was found. Therefore, it can be considered an oncologically safe procedure in suitable patients with careful oncological follow-up. In the future, more longterm, adequately powered, multicentre controlled studies are needed. Additionally, more research should be carried out on the incidence of complications following lipofilling so that efforts can be made to prevent them and optimise fat graft survival.
This is a pre-copyedited, author-produced PDF of an article accepted for publication in QJM: An International Journal of Medicine following peer review. The version of record [Oncological Safety of Lipofilling in Patients with Breast Cancer: A Metaanalysis. QJM: An International Journal of Medicine 114, Supplement_1 (2021)] is available online at: https://doi.org/10.1093/qjmed/hcab105.007. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing [email protected]
Vasopressor use after noncardiac surgery: an international observational study
No full textBackground: Hypotension after major noncardiac surgery is associated with increased morbidity, mortality, and costs, and is often treated with postoperative vasopressor infusions. The frequency of administration in the postoperative period is unknown. Methods: This international prospective cohort study was conducted between October 2020 and October 2023. At each hospital, adults undergoing noncardiac surgery were enrolled into two cohorts: all consecutive patients for 1 week (Cohort A) and an additional sample of up to 30 consecutive patients administered postoperative vasopressor infusions within 1 yr (Cohort B). The primary outcome (Cohort A) was the incidence of postoperative vasopressor infusions, defined as any continuous infusion of vasopressors. Secondary outcomes included in-hospital mortality, organ dysfunction, length of hospital stay, and complications associated with postoperative vasopressor infusions (both cohorts). Results: In total, 25 675 participants were enrolled from 228 hospitals across 42 countries. In Cohort A, 770/19 768 (3.9%) participants received postoperative vasopressor infusions, with vasopressor use ranging between 0% and 18% across hospitals (median odds ratio: 2.30 [credible interval 1.96–2.73]). This variability did not alter after adjustment for case-mix and procedural characteristics. For both cohorts, postoperative vasopressor infusions were associated with higher (15.5%) in-hospital mortality, higher rates of organ failure, and longer hospital stay. Conclusions: Administration of postoperative vasopressors after noncardiac surgery varied across hospitals and was associated with worse outcomes. Variable practice across hospitals could not be explained by differences in case-mix. Clinical trial registration: https://clinicaltrials.gov/study/NCT03805230, ESAIC tracking ID: ESAIC_CTN_SQUEEZE
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries
No full textBackground: Pancreatic surgery remains associated with high morbidity rates. Although postoperative mortality appears to have improved with specialization, the outcomes reported in the literature reflect the activity of highly specialized centres. The aim of this study was to evaluate the outcomes following pancreatic surgery worldwide.Methods: This was an international, prospective, multicentre, cross-sectional snapshot study of consecutive patients undergoing pancreatic operations worldwide in a 3-month interval in 2021. The primary outcome was postoperative mortality within 90 days of surgery. Multivariable logistic regression was used to explore relationships with Human Development Index (HDI) and other parameters.Results: A total of 4223 patients from 67 countries were analysed. A complication of any severity was detected in 68.7 percent of patients (2901 of 4223). Major complication rates (Clavien-Dindo grade at least IIIa) were 24, 18, and 27 percent, and mortality rates were 10, 5, and 5 per cent in low-to-middle-, high-, and very high-HDI countries respectively. The 90-day postoperative mortality rate was 5.4 per cent (229 of 4223) overall, but was significantly higher in the low-to-middle-HDI group (adjusted OR 2.88, 95 per cent c.i. 1.80 to 4.48). The overall failure-to-rescue rate was 21 percent; however, it was 41 per cent in low-to-middle-compared with 19 per cent in very high-HDI countries.Conclusion: Excess mortality in low-to-middle-HDI countries could be attributable to failure to rescue of patients from severe complications. The authors call for a collaborative response from international and regional associations of pancreatic surgeons to address management related to death from postoperative complications to tackle the global disparities in the outcomes of pancreatic surgery (NCT04652271; ISRCTN95140761)
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries
No full textBackground: Pancreatic surgery remains associated with high morbidity rates. Although postoperative mortality appears to have
improved with specialization, the outcomes reported in the literature reflect the activity of highly specialized centres. The aim of
this study was to evaluate the outcomes following pancreatic surgery worldwide.
Methods: This was an international, prospective, multicentre, cross-sectional snapshot study of consecutive patients undergoing
pancreatic operations worldwide in a 3-month interval in 2021. The primary outcome was postoperative mortality within 90 days of
surgery. Multivariable logistic regression was used to explore relationships with Human Development Index (HDI) and other parameters.
Results: A total of 4223 patients from 67 countries were analysed. A complication of any severity was detected in 68.7 per cent of
patients (2901 of 4223). Major complication rates (Clavien–Dindo grade at least IIIa) were 24, 18, and 27 per cent, and mortality rates
were 10, 5, and 5 per cent in low-to-middle-, high-, and very high-HDI countries respectively. The 90-day postoperative mortality
rate was 5.4 per cent (229 of 4223) overall, but was significantly higher in the low-to-middle-HDI group (adjusted OR 2.88, 95 per
cent c.i. 1.80 to 4.48). The overall failure-to-rescue rate was 21 per cent; however, it was 41 per cent in low-to-middle- compared
with 19 per cent in very high-HDI countries.
Conclusion: Excess mortality in low-to-middle-HDI countries could be attributable to failure to rescue of patients from severe
complications. The authors call for a collaborative response from international and regional associations of pancreatic surgeons to
address management related to death from postoperative complications to tackle the global disparities in the outcomes of pancreatic
surgery (NCT04652271; ISRCTN95140761)
